King International Investment (HKSE:00928) Interest Expense : HK$-0.3 Mil (TTM As of Sep. 2023)

View and export this data going back to 2002. Start your Free Trial

What is King International Investment Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. King International Investment's interest expense for the six months ended in Sep. 2023 was HK$ -0.1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-0.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. King International Investment's Operating Income for the six months ended in Sep. 2023 was HK$ 2.8 Mil. King International Investment's Interest Expense for the six months ended in Sep. 2023 was HK$ -0.1 Mil. King International Investment's Interest Coverage for the quarter that ended in Sep. 2023 was 30.21. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

King International Investment Interest Expense Historical Data

The historical data trend for King International Investment's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

King International Investment Interest Expense Chart

King International Investment Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Interest Expense

Get a 7-Day Free Trial

-0.51

-0.06

-0.02

-0.23

King International Investment Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Interest Expense	Get a 7-Day Free Trial															-0.01	-0.01	-0.05	-0.18	-0.09

King International Investment Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.3 Mil.

King International Investment (HKSE:00928) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

King International Investment's Interest Expense for the six months ended in Sep. 2023 was HK$-0.1 Mil. Its Operating Income for the six months ended in Sep. 2023 was HK$2.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2023 was HK$1.5 Mil.

King International Investment's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2023 )	/	Interest Expense (Q: Sep. 2023 )
	=	-1	*	2.779	/	-0.092
	=	30.21

The higher the ratio, the stronger the company's financial strength is.

King International Investment (HKSE:00928) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Harbour Road, Room 6307-08, 63rd Floor, Central Plaza, Wanchai, Hong Kong, HKG

Website

https://www.lifehealthcare.com

King International Investment Ltd formerly Life Healthcare Group Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business and Money lending business. It generates maximum revenue from the Healthcare products and services business segment. Geographically, it derives a majority of revenue from PRC. The group is primarily a provider of genetic testing and health data analysis services.

King International Investment (HKSE:00928) Headlines

No Headlines